The role of hypoxia-induced factors in tumor progression

Oncologist

Volumn 9, Issue SUPPL. 5, 2004, Pages 10-17

  Vaupel, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Genome changes; HIF 1 ; Hypoxia; Proteome changes

Indexed keywords

GLUCOSE; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN; TRANSCRIPTION FACTOR;

ANAEROBIC METABOLISM; ANGIOGENESIS; CANCER GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; GENE EXPRESSION; GENOMICS; GLUCOSE METABOLISM; HUMAN; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REOXYGENATION; TUMOR CELL; VASCULARIZATION;

EID: 10644234769     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-90005-10     Document Type: Conference Paper

References (55)

1. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000;6:157-162.
2. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465.
3. Ryan HE, Poloni M, McNulty W et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 2000;60:4010-4015.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
5. Vaupel P, Briest S, Höckel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 2002;152:334-342.
6. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-276.
7. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. The Oncologist 2004;9(suppl 5):4-9.
8. Moulder JE, Rockwell S. Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 1987;5:313-341.
9. Durand RE. Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. Int J Radiat Oncol Biol Phys 1991;20:253-258.
10. Giaccia AJ. Hypoxic stress proteins: survival of the fittest. Semin Radiat Oncol 1996;6:46-58.
11. Riva C, Chauvin C, Pison C et al. Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res 1998;18:4729-4736.
12. Haroon ZA, Raleigh JA, Greenberg CS et al. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 2000;231:137-147.
13. Krishnamachary B, Berg-Dixon S, Kelly B et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138-1143.
14. Koong AC, Denko NC, Hudson KM et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883-887.
15. Czekay RP, Aertgeerts K, Curriden SA et al. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 2003;160:781-791.
16. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. MoI Cell Biol 1992;12:5447-5454.
17. 2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
18. Wang GL, Semenza GL. Purification and characterization of hypoxia-induciblefactor 1. J Biol Chem 1995;270:1230-1237.
19. Semenza GL.Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71-103.
20. Giordano FJ, Johnson RS. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 2001;11:35-40.
21. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001;11:293-299.
22. Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res 2001;49:614-617.
23. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 2001;107:1-3.
24. Semenza GL. Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J Clin Invest 2001;108:39-40.
25. Goonewardene TI, Sowter HM, Harris AL. Hypoxia-induced pathways in breast cancer. Microsc Res Tech 2002;59:41-48.
26. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002;8(suppl 4):S62-S67.
27. Hanahan D, Christofori G, Naik P et al. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 1996;32A:2386-2393.
28. Pepper MS, Ferrara N, Orci L et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-906.
29. Pepper MS, Vassalli JD, Orci L et al. Proteolytic balance and capillary morphogenesis in vitro. EXS 1992;61:137-145.
30. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613.
31. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13:29-37.
32. Carmeliet P, Dor Y, Herbert JM et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-490.
33. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-3015.
34. Leibovich SJ, Polverini PJ, Shepard HM et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-632.
35. Leek RD, Hunt NC, Landers RJ et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000;190:430-436.
36. 2- regulated gene expression. FASEB J 2002;16:1151-1162.
37. Ravi R, Mookerjee B, Bhujwalla ZM et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 2000;14:34-44.
38. Semenza GL, Jiang BH, Leung SW et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271:32529-32537.
39. Semenza GL, Roth PH, Fang HM et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994;269:23757-23763.
40. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 1994;54:1425-1430.
41. Laderoute KR, Calaoagan JM, Gustafson-Brown C et al. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol 2002;22:2515-2523.
42. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-5757.
43. Yuan J, Glazer PM. Mutagenesis induced by the tumor microenvironment. Mutat Res 1998;400:439-446.
44. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001;18:243-259.
45. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol 2000;76:589-605.
46. Yuan J, Narayanan L, Rockwell S et al. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000;60:4372-4376.
47. Cheng KC, Cahill DS, Kasai H et al. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J Biol Chem 1992;267:166-172.
48. Olinski R, Gackowski D, Foksinski M et al. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 2002;33:192-200.
49. Coquelle A, Toledo F, Stern S et al. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 1998;2:259-265.
50. Russo CA, Weber TK, Volpe CM et al. An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res 1995;55:1122-1128.
51. Graeber TG, Osmanian C, Jacks T et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
52. Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001;28(suppl 8):36-41.
53. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 2001;61:8903-8908.
54. Österborg A. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned? Med Oncol 1998;15(suppl 1):S47-S49.
55. Dunst J, Feldmann HJ, Becker A et al. Oxygenation of human tumors: the Munich/Halle experiments. In: Vaupel P, Kelleher DK, eds. Tumor Hypoxia. Pathophysiology, Clinical Significance and Therapeutic Perspectives. Stuttgart, Germany. Wissenschaftl Verlagsgesellschaft, 1999:39-46.